Cargando…
Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure
BACKGROUND: Mesenchymal stem cells (MSCs) are a heterogeneous group of subpopulations with differentially expressed surface markers. CD146 + MSCs correlate with high therapeutic and secretory potency. However, their therapeutic efficacy and mechanisms in premature ovarian failure (POF) have not been...
Autores principales: | Zhang, Lin, Sun, Yang, Zhang, Xiao-Xu, Liu, Yu-Bin, Sun, Hui-Yan, Wu, Chu-Tse, Xiao, Feng-Jun, Wang, Li-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209844/ https://www.ncbi.nlm.nih.gov/pubmed/35729643 http://dx.doi.org/10.1186/s13287-022-02916-x |
Ejemplares similares
-
CD146+ Umbilical Cord Mesenchymal Stem Cells Exhibit High Immunomodulatory Activity and Therapeutic Efficacy in Septic Mice
por: Zhang, Lin, et al.
Publicado: (2023) -
Umbilical cord artery-derived perivascular stem cells for treatment of ovarian failure through CD146 signaling
por: Xu, Lu, et al.
Publicado: (2022) -
Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure
por: Shi, Lan, et al.
Publicado: (2022) -
The Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Mice Premature Ovarian Failure
por: Wang, Shufang, et al.
Publicado: (2013) -
Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
por: Huang, Yanjing, et al.
Publicado: (2022)